CUMBERLAND PHARMACEUTICALSCPIX
ASignal's systematic analysis rates CPIX as Bearish.
Reflects the latest available analysis · analyzed Oct 23, 2026
The case on CPIX
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- MACD indicates bullish momentum with MACD above signal line and expanding histogram
- Price trading above 20-day and 50-day moving averages (SMA20: 7.43, SMA50: 7.41)
- Strong gross margin of 84.95% indicating pricing power or low cost structure
- Low debt-to-equity ratio of 0.28x suggesting conservative capital structure
- Current price near upper Bollinger Band (8.34), indicating potential strength
- Negative net and operating margins (net margin: -24.64%, operating margin: -1898.65%)
- Negative free cash flow of $-191,169
- Sharp year-over-year revenue decline of -56.30%
- Extremely high EV/EBITDA of 116.33x, suggesting valuation concerns
- Low current and quick ratios (0.96x, 0.49x) indicating potential liquidity risk
See the full verdict on CPIX
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes CPIX
Most investors never get a second opinion, let alone several. ASignal runs CPIX past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.